Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

  • Filters activated: AIDS. Clear all to show 1874 items.
1.
2.

Inhibition of early and late phase allergic reactions by Euphorbia hirta L.

Singh GD, Kaiser P, Youssouf MS, Singh S, Khajuria A, Koul A, Bani S, Kapahi BK, Satti NK, Suri KA, Johri RK.

Phytother Res. 2006 Apr;20(4):316-21.

PMID:
16557622
3.

Cold urticaria associated with acute serologic toxoplasmosis.

Miralles López JC, López Andreu FR, Sánchez-Gascón F, López Rodríguez C, Negro Alvarez JM.

Allergol Immunopathol (Madr). 2005 May-Jun;33(3):172-4.

PMID:
15946632
4.

Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers.

Peytavin G, Gautran C, Otoul C, Cremieux AC, Moulaert B, Delatour F, Melac M, Strolin-Benedetti M, Farinotti R.

Eur J Clin Pharmacol. 2005 Jun;61(4):267-73. Epub 2005 May 12.

PMID:
15889300
5.

Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters.

Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wójcik K, Szmyd D, Adamek-Guzik T, Pryjma J.

Clin Exp Allergy. 2005 Apr;35(4):448-55.

PMID:
15836752
6.

Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.

Knobel H, Miró JM, Mahillo B, Domingo P, Rivero A, Ribera E, Gonzalez J, Sanz J, González A, Blanco JL, Boix V, Force L, Llibre JM, Dalmau D, Arroyo JA, De la Torre J, Rodriguez D, Montes ML, Arranz A, Sarasa M; Grupo Estudio Syndrome Immunodeficiencies Adquirida 26/02 Study Group.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1276-81.

PMID:
15385735
7.

Eosinophilic pustular folliculitis: a comprehensive review of treatment options.

Ellis E, Scheinfeld N.

Am J Clin Dermatol. 2004;5(3):189-97. Review.

PMID:
15186198
8.

Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.

Launay O, Roudière L, Boukli N, Dupont B, Prévoteau du Clary F, Patey O, David F, Lortholary O, Devidas A, Piketty C, Rey E, Urbinelli R, Allaert FA, Tréluyer JM, Caumes E; Viramune-Zyrtec Study Group.

Clin Infect Dis. 2004 Apr 15;38(8):e66-72. Epub 2004 Mar 29.

PMID:
15095233
9.

Incidence and risk factors for nevirapine-associated rash.

de Maat MM, ter Heine R, Mulder JW, Meenhorst PL, Mairuhu AT, van Gorp EC, Huitema AD, Beijnen JH.

Eur J Clin Pharmacol. 2003 Sep;59(5-6):457-62. Epub 2003 Aug 12.

PMID:
12920493
10.

Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.

Ometto L, Zanchetta M, Mainardi M, De Salvo GL, Garcia-Rodriguez MC, Gray L, Newell ML, Chieco-Bianchi L, De Rossi A.

AIDS. 2000 Aug 18;14(12):1721-9.

PMID:
10985308
11.

[Ofuji's eosinophilic pustular folliculitis. Efficacy of acitretin].

Dubost-Brama A, Delaporte E, Catteau B, Warembourg A, Piette F, Bergoend H.

Ann Dermatol Venereol. 1997;124(8):540-3. French.

PMID:
9740848
12.

Effect of cetirizine on the inflammatory cells in mosquito bites.

Karppinen A, Rantala I, Vaalasti A, Palosuo T, Reunala T.

Clin Exp Allergy. 1996 Jun;26(6):703-9.

PMID:
8809428
13.

Eosinophilic pustular folliculitis in an HIV-positive man: response to cetirizine.

Harris DW, Ostlere L, Buckley C, Johnson M, Rustin MH.

Br J Dermatol. 1992 Apr;126(4):392-4.

PMID:
1349234
14.

Cetirizine does not influence the immune response.

Canonica GW, Pesce G, Ruffoni S, Buscaglia S, Boero F, Jing G, Rihoux JP, Ciprandi G.

Ann Allergy. 1992 Mar;68(3):251-4.

PMID:
1347675

Supplemental Content

Loading ...
Support Center